This month’s “Company Spotlight” provides a closer look at the Finnish-Swiss company BC Platforms, a genomic data management and analysis solutions provider, working to revolutionize drug development and to enable...read more
Archive - 2019
An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine
The following is an interview I recently conducted for the PMWC Intl. team with Dr. Mike Snyder, Professor of Genetics at Stanford University, and in essence is a repost of the original interview that can be found on...read more
Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment
For this month’s “Company Spotlight” blog series we are reviewing Nebion, a Swiss bioinformatics company, in an interview with Philip Zimmermann, Co-founder and CEO of Nebion. Nebion is a 30-person company headquartered...read more
Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”
The following is an interview I recently conducted for the PMWC Intl. team with Dr. Mike Pellini, Managing Partner of Section 32 (former CEO of Foundation Medicine), and in essence is a repost of the original interview...read more
Basepair Provides an Intuitive, Easy-to-Use NGS Data Analysis Platform Which Does Not Require Coding Skills
This month’s Company Spotlight provides a closer look at Basepair, a developer and supplier of a suite of automated NGS analysis solutions for research, clinical, and pharma teams. The company’s mission is to provide an...read more
Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases
This month’s “Company Spotlight” takes a closer look at Othram Inc which applies the power of modern sequencing technology and genomics to forensics. David Mittelman, Chief Executive Officer of Othram, discussed with us...read more
Immunotherapy and the Basis of Neoantigen Biology: Part II Cancer Immunotherapies
Last month’s Immunotherapy and the Basis of Neonatigen Biology blog post focused on neoantigens along with some facets of immunology and cancer that are interrelated. We described in detail how neoantigens and other...read more
BioIT 2019: The New “Official” Future Involves Data Sharing, Artificial Intelligence, Open Source, and More
The 18th installment of Boston’s Bio-IT World Conference was attended by over 3,400 participants and featured more than 185 exhibiting companies, both established and startups. The conference program kicked off with a...read more
Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens
Since the dawn of the 20th century it was thought that the immune system could ultimately play a role in the treatment of cancers (Wirth and Kunhel, 2017). There has been a resurgence of interest in the last decades in...read more
Sentieon Solves Complex Mathematical Problems – Applied to DNA Sequence Secondary Data Analysis – by Enhancing them With Extreme Accuracy and Efficiency
This month’s “Company Spotlight” provides a closer look at Sentieon, a developer and supplier of a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast...read more
AGBT 2019, And the Winners are “Spatial Genomics, Single-cell Genomics, and Long-read Sequencing”
For the first time in three years AGBT returned to Marco Island for its 2019 conference. It was pleasant to be back and be able to enjoy the warmth and the friendly setting we’ve all remembered. The weather played along...read more
Blueprint Genetics Aims to Automate and Improve Clinical Interpretation Processes with Software That Will Change the Industry
This month’s “Company Spotlight” takes a closer look at Blueprint Genetics, a rare disease diagnostics company on a mission to deliver the highest quality standards for genetic diagnostics. Tero-Pekka Alastalo, Chief...read more
JP Morgan 2019 – Drug pricing, drug development, immunotherapy, cancer moonshot, cell/gene-therapy, …
As we all know the JP Morgan Healthcare conference is an invitation-only conference. For this reason, I have summarized various announcements for the purpose of this review. As we have witnessed in the past, exciting...read more
Review of Emerging 2018 Genomic Variants – a Genomenon Research Report
2018 has been another banner year in the progression of Precision Medicine! Year over year, there has been a dramatic rise in the number of scientific studies and initiatives that resulted in meaningful published...read more
2018: Population Studies, Immunotherapy, CRISPR, Genomic Medicine,…2019
2018 was full of significant developments in the life sciences, precision medicine, genetics, and genomics sector. Highlights and notable news included various technological advancements, new clinical applications of...read more
